Skip to main navigation Skip to search Skip to main content

Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors

  • Aarón Mendieta
  • , Fabiola Jiménez
  • , Leticia Garduño-Siciliano
  • , Angélica Mojica-Villegas
  • , Blanca Rosales-Acosta
  • , Lourdes Villa-Tanaca
  • , Germán Chamorro-Cevallos
  • , José L. Medina-Franco
  • , Nathalie Meurice
  • , Rsuini U. Gutiérrez
  • , Luisa E. Montiel
  • , María Del Carmen Cruz
  • , Joaquín Tamariz

Research output: Contribution to journal › Article › peer-review

Abstract

In the search for new potential hypolipidemic agents, the present study focused on the synthesis of 2-acyl phenols (6a-c and 7a-c) and their saturated side-chain alkyl phenols (4a-c and 5a-c), and on the evaluation of their hypolipidemic activity using a murine Tyloxapol-induced hyperlipidemic protocol. The whole series of compounds 4-7 greatly and significantly reduced elevated serum levels of total cholesterol, LDL-cholesterol, and triglycerides, with series 6 and 7 showing the greatest potency ever found in our laboratory. At the minimum dose (25 mg/kg/day), the latter compounds lowered cholesterol by 68-81%, LDL by 72-86%, and triglycerides by 59-80%. This represents a comparable performance than that shown by simvastatin. Experimental evidence and docking studies suggest that the activity of these derivatives is associated with the inhibition of HMG-CoA reductase.

Original languageEnglish (US)
Pages (from-to)5871-5882
Number of pages12
JournalBioorganic and Medicinal Chemistry
Volume22
Issue number21
DOIs
StatePublished - Nov 1 2014

Keywords

  • Docking 2-Acyl phenols 2-Alkyl phenols
  • HMG-CoA reductase
  • Hypolipidemic
  • Phenoxyacetic

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors'. Together they form a unique fingerprint.

Cite this